- WELL announces the launch of WELL AI Decision Support, to help healthcare providers improve early disease diagnosis and preventive health.
- WELL partners exclusively with HEALWELL AI, a leader in AI-powered disease diagnosis, to power its solutions in both Canada and the United States.
- WELL’s goal is to make AI-based decision support a core offering for all physicians, supported by its SaaS and fully managed platforms that collectively power more than 31,000 physicians and other care providers worldwide. Canada and the United States.
- From October 1st2023, HEALWELL AI closed its doors $18 million in financing including a 10 million dollars convertible debenture round led by WELL Health, which is now the largest shareholder of HEALWELL AI, on an as-converted basis.
VANCOUVER, BC And TORONTO, October 18, 2023 /PRNewswire/ – WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (“GOOD“), a digital health company focused on cutting-edge healthcare providers, and the company it invests in, HEALWELL AI (TSX: AIDX) (“HEAL WELL“), are pleased to announce the launch of “WELL AI decision support”, a revolutionary new service for healthcare providers. This partnership is the first major collaborative initiative between the two companies since the announcement of the strategic alliance agreement on October 3, 2023. Both companies view this as the start of a mutually beneficial, long-term partnership, with a shared vision and commitment to continued innovation.
Hamed Shahbazifounder and CEO of WELL commented: “We strongly believe that the physician experience of the not-so-distant future will involve a number of safe, secure and useful digital diagnostic tools that will better help healthcare providers detect earlier acute and chronic illnesses. The launch of “WELL AI Decision Support” perfectly aligns with our core strategy to empower healthcare providers with transformative technology, strengthening their ability to improve patient outcomes and promote preventative health.
Dr. Michael FrankelChief Medical Officer of WELL, added: “The arrival of “WELL AI Decision Support” marks more than just technological progress; this is a defining moment in our pursuit of superior patient care. By harnessing the potential of AI, we equip healthcare professionals with tools. who refine and elevate their practice. Every patient deserves individualized attention and precise care, and this module is a step forward in realizing that vision.
Dr. Alexander DobranowskiCEO of HEALWELL AI, said: “Our partnership with WELL is a strategic imperative in healthcare. The alignment between HEALWELL’s pioneering data science and WELL’s extensive clinical network underscores the strength of our collaboration. Together with WELL’s robust healthcare software solutions, we are creating a synergy poised to redefine healthcare standards. This partnership amplifies our combined commitment to leveraging data science for healthcare applications, ultimately benefiting patients and healthcare providers.
The “WELL AI Decision Support” module is a revolutionary solution that fills a critical gap in health diagnostics and patient care, ushering in a new era of precision in healthcare delivery. WELL AI Decision Support leverages artificial intelligence (AI) technologies to enable earlier diagnosis, treatment and improved patient quality of life. The technology behind WELL AI Decision Support was meticulously developed by HEALWELL, working closely with dedicated physicians, leading researchers, data privacy professionals, pharmaceutical companies and other domain experts. This rigorous development and refinement process has led to its validation in the Canadian and American health systems. WELL AI Decision Support is also a highly modular service that will be expanded over time. As a first step, the service enables healthcare providers to accurately identify more than 110 complex or rare diseases, often overlooked by traditional methods, giving hope to thousands of patients around the world. Canada.
“WELL AI Decision Support” is the second significant product release of the WELLHealth.ai program, following the successful “WELL AI Voice” module, and once again illustrates WELL’s unwavering commitment and leadership in providing decision support solutions. Effective AI in healthcare. WELL AI Decision Support is featured on apps.health, WELL’s premium digital marketplace for EMR tools and applications.
Rare and complex diseases affect more than 300 million patients worldwide. Canada, 1 in 12 people live with a rare disease. What is even more alarming is the significant number of people who go undiagnosed and unaware of their underlying conditions. For those who experience symptoms, the journey to a correct diagnosis is arduous. On average, they consult 8 doctors and experience 2-3 misdiagnoses over a period of 4.8 years before receiving an accurate diagnosis.
This partnership represents a significant victory for HEALWELL, granting expanded access to healthcare providers. The launch of the “WELL AI Decision Support” module highlights the trust and validation of HEALWELL’s expertise within the industry. WELL and HEALWELL plan to continue collaborating to combine their expertise and capabilities for more revolutionary developments in the future.
For detailed information about WELL AI decision support, please visit https://decisionsupport.wellhealth.ai/.
WELL HEALTH TECHNOLOGIES CORP.
By: “Hamed Shahbazi”
Hamed Shahbazi
Managing Director, President and Administrator
About WELL Health Technologies Corp.
WELL’s mission is to provide state-of-the-art healthcare providers. We achieve this by developing the best technology, services and support available, ensuring healthcare providers are empowered to positively impact patient outcomes. WELL’s comprehensive healthcare and digital platform includes numerous front-office and back-office management software applications that help physicians manage and secure their practices. WELL’s solutions enable more than 31,000 healthcare providers across the United States and Canada and power the world’s largest owned and operated healthcare ecosystem Canada with more than 148 clinics offering primary care, specialty care and diagnostic services. In United States WELL’s solutions focus on specialty markets such as the gastrointestinal market, women’s health, primary care and mental health. WELL is listed on the Toronto Stock Exchange under the symbol “WELL” and on the OTC Exchange under the symbol “WHTCF”. To learn more about WELL, please visit: www.well.company.
About HEALWELL AI Inc.
HEALWELL AI is a healthcare technology company focused on AI and data science for preventive care. Its mission is to improve health care and save lives through the early identification and detection of disease. As a physician-led organization with a proven leadership team of experienced executives, HEALWELL AI executes a strategy focused on developing and acquiring technology and clinical science capabilities that complement the company’s roadmap. the company. HEALWELL AI is listed on the Toronto Stock Exchange under the symbol AIDX. To learn more about HEALWELL AI, please visit: https://healwell.ai/.
Forward-looking statements
This press release may contain “forward-looking information” within the meaning of applicable Canadian securities laws, including, without limitation: information regarding the objectives, strategies and growth plans of WELL and HEALWELL, including including collaboration projects and deployment of new AI technologies; future voting rights and control, as well as expectations regarding revenue and EBITDA. Forward-looking information is necessarily based on a number of estimates and assumptions which, although considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking information generally can be identified by the use of forward-looking words such as “may”, “should”, “will”, “could”, “intend”, “estimate”, “plan”, “anticipate” », “expect”, “believe” or “continue”, or their negative form or similar variations. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause future results, performance or achievements to be materially different from any estimated future results, performance or achievements expressed or implied by the information. Forward-looking and Forward-looking information is not a guarantee of future performance. WELL’s comments expressed or implied in such forward-looking information are subject to a number of risks, uncertainties and conditions, many of which are beyond WELL’s control, and undue reliance should not be placed on such information. Forward-looking information in its entirety is subject to inherent risks and uncertainties, including: the direct and indirect material adverse effects of the COVID-19 pandemic; unfavorable market conditions; risks inherent to the primary health care sector in general; regulatory and legislative changes; that future results may differ from historical results; that competition in the market may affect WELL’s business, results and financial condition as well as other risk factors identified in documents filed by WELL under its profile at www.sedarplus.ca, including its most recent annual information form. Except as required by securities law, WELL undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, events or otherwise.
SOURCE WELL Health Technologies Corp.
